1. Home
  2. Research
  3. Research Groups
  4. Drug utilisation and health outcomes of pharmacotherapy

Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Fernández-Fradejas J, Martínez-Barros H, Rexach-Cano L, Álvarez-Díaz AM, Delgado-Silveira E.

    Deprescribing in older patients with advanced cancer referred to palliative care.

    BMJ Supportive & Palliative Care . : .

    [doi:10.1136/spcare-2024-004849]

  • Herrero Domínguez-Berrueta MC, Muñoz-García M, Delgado-Silveira E, Martín-Aragón S, Gangoso Fermoso A.

    Primary care pharmacist-led medication review in older adult patients in coordination with general practitioners: an observational retrospective cohorts study.

    Exploratory Research In Clinical And Social Pharmacy . 13: 100390-100390. Number of citations: 1

    [doi:10.1016/j.rcsop.2023.100390]

  • Esteban-Cartelle B, Serrano DR, Pérez Menéndez-Conde C, Vicente-Oliveros N, Álvarez-Díaz A, Abete JF, Martín-Dávila P.

    Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

    Microbiology spectrum . 12(2): .

    [doi:10.1128/spectrum.02063-23]

  • VÉLEZ DÍAZ-PALLARÉS, MANUEL, MONTERO LLORENTE, BEATRIZ, PARRO MARTÍN, MARÍA DE LOS ÁNGELES, MOLINA MENDOZA, MARIA DOLORES, HERNÁNDEZ HUERTA, DANIEL, ÁLVAREZ DÍAZ, ANA MARIA.

    Pérdida de vinculación con el sistema sanitario de las personas que viven con VIH

    REVISTA MULTIDISCIPLINAR DEL SIDA . 12: .

  • Rodríguez-Otero N, Fernández-Lozano C, Vicente-Santamaría S, Díaz-Montalvo L, Menéndez-Conde C, Sola-Martínez FJ.

    Rapid drug desensitization protocol in delayed hypersensitivity reactions to CFTR modulator drugs: When everyday counts.

    Journal of investigational allergology & clinical immunology . 34(5): 0-0.

    [doi:10.18176/jiaci.0982]

  • Blanco-Arévalo JL, García-Deltoro M, Torralba M, Vélez-Díaz-Pallarés M, Castro A, Rubio-Rodríguez D, Rubio-Terrés C.

    HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.

    AIDS REVIEWS . 26(2): 67-79.

    [doi:10.24875/AIDSRev.24000011]

  • Martínez-Moragón E, Antepara Ercoreca I, Muñoz García M, Casas Maldonado F, Calvín Lamas M, Chiner Vives E, Crespo Diz C, Díaz-Pérez D, Eguiluz Gracia I, García Gil S, González-Pérez R, Habernau Mena A, Hermida Valverde T, Jornet Montaña S, López-Carrasco V, Martínez López I, Merino-Bohórquez V, Moreno-Ancillo Á, Mínguez Cabeza AC, Monte-Boquet E, Revuelta-Herrero JL, Sánchez-Cuellar S.

    Patient-reported outcome measures in severe asthma: an expert consensus.

    JOURNAL OF ASTHMA . 61(6): 1-13. Number of citations: 3

    [doi:10.1080/02770903.2023.2297372]

  • Vélez-Díaz-Pallarés M, Delgado-Silveira E, Fernández-Fradejas J, Montero-Llorente B, Palomar-Fernández C, Montero-Errasquín B, Cruz-Jentoft AJ, Álvarez-Díaz A.

    Potentially Inappropriate Prescribing in Older People Living With HIV: A Scoping Review

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 94(5): 445-460. Number of citations: 5

    [doi:10.1097/QAI.0000000000003298]

  • Esteban-Cartelle B, Serrano DR, Pérez Menéndez-Conde C, Vicente-Oliveros N, Álvarez-Díaz A, Fortún Abete J, Martín-Dávila P.

    Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

    Microbiology spectrum . 12(1): . Number of citations: 3

    [doi:10.1128/spectrum.02064-23]

  • Calvin-Lamas M, Calleja Hernández MÁ, Monte-Boquet E, Rodriguez Sagrado MÁ, Ventayol Bosch P.

    [Translated article] Checklist for the pharmaceutical care of patients with interstitial lung disease (CheckEPID): A Delphi-based consensus

    FARMACIA HOSPITALARIA . 47(6): 277-284.

    [doi:10.1016/j.farma.2023.09.004]

  • Delgado-Silveira E, José PB, García MTL, Alonso EAÁ, García MM, Correas FJH.

    [Translated article] Deglufarm: Mobile application with recommendations for the safe administration of drugs in patients with dysphagia or swallowing disorders.

    FARMACIA HOSPITALARIA . 47(6): 285-288.

    [doi:10.1016/j.farma.2023.08.002]

  • Delgado-Silveira E, Bravo José P, Llanos García MT, Álvaro Alonso EA, Muñoz García M, Hidalgo Correas FJ.

    Deglufarm: Mobile application with recommendations for safety drug administration in patients with dysphagia or deglution disorders.

    FARMACIA HOSPITALARIA . 47(6): 285-288.

    [doi:10.1016/j.farma.2023.06.005]

  • Calvin Lamas M, Calleja Hernández MÁ, Monte-Boquet E, Rodriguez Sagrado MÁ, Ventayol Bosch P.

    Checklist for Pharmaceutical Care of the Patient with interstitial lung disease (CheckEPID): A Delphi-based consensus

    FARMACIA HOSPITALARIA . 47(6): 277-284. Number of citations: 2

    [doi:10.1016/j.farma.2023.06.010]

  • Delgado-Silveira E, Molina Mendoza MD, Montero-Errasquín B, Muñoz García M, Rodríguez Espeso EA, Vélez-Díaz-Pallarés M, Cruz-Jentoft AJ.

    [Spanish version of the STOPP/START 3 criteria: Advances in the detection of inappropriate prescribing medication in the older people].

    Revista espanola de geriatria y gerontologia . 58(5): 101407-101407.

    [doi:10.1016/j.regg.2023.101407]

  • Ojeda IM, Sánchez-Cuervo M, Candela-Toha Á, Serrano-López DR, Bermejo-Vicedo T, Alcaide-López-de-Lerma JM.

    Protocolization of Analgesia and Sedation Through Smart Technology in Intensive Care: Improving Patient Safety.

    CRITICAL CARE NURSE . 43(4): 30-38.

    [doi:10.4037/ccn2023271]

  • García-Ruiz de Morales AG, Martínez-Sanz J, Vivancos-Gallego MJ, Sánchez-Conde M, Vélez-Díaz-Pallarés M, Romero-Hernández B, Vázquez MDG, de Luque CMC, González-Sarria A, Galán JC, Rodríguez FG, Moreno S, Pérez-Elías MJ.

    HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

    Frontiers in Public Health . 11: 1136988-1136988. Number of citations: 6

    [doi:10.3389/fpubh.2023.1136988]

  • Velez-Diaz-Pallares, M, Esteban-Cartelle, B, Gramage-Caro, T, Montero-Llorente, B, Parro-Martin, MD, Rodriguez-Sagrado, MA, Alvarez-Diaz, AM.

    Disorders in sleep quality associated with integrase inhibitors in the treatment of HIV

    REVISTA ESPANOLA DE SALUD PUBLICA . 97: .

  • Vélez-Díaz-Pallarés M, Esteban-Cartelle B, Gramage-Caro T, Montero-Llorente B, Parro-Martín MLÁ, Rodríguez-Sagrado MÁ, Álvarez-Díaz AM.

    Trastornos en la calidad del sueño asociados a los inhibidores de la integrasa en el tratamiento del VIH.

    REVISTA ESPANOLA DE SALUD PUBLICA . 97: .